Skip to main content
Erschienen in: Urolithiasis 4/2011

01.08.2011 | Original Paper

Complete supine percutaneous nephrolithotomy (csPCNL) in patients with and without a history of stone surgery: safety and effectiveness of csPCNL

verfasst von: Siavash Falahatkar, Mani Mohiti Asli, Seyedeh Atefeh Emadi, Ahmad Enshaei, Hedayat Pourhadi, Aliakbar Allahkhah

Erschienen in: Urolithiasis | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

To determine the effects of previous stone surgery on the results of complete supine percutaneous nephrolithotomy (csPCNL), we reviewed 81 patients undergoing csPCNL at our center between March 2008 and March 2009. The principal aim in our study was whether prior renal surgery affects the outcome of PCNL. The results of the study were analyzed using SPSS 11 software. Our patients were divided to in two groups. Group 1 consisted of patients with a previous history of renal stone surgery and group 2 consisted of patients without history of renal surgery. Mean operative time in group 1 was 98.75 ± 56.31 min, and in group 2 99.71 ± 45.9 min (p = 0.93). Bleeding requiring transfusion occurred in four (14.2%) patients in group 1, and in eight (15.09%) patients in group 2 (p = 0.826). Fever was detected in no patients in group 1, and in four (7.5%) patients in group 2 (p = 0.136). Postoperative hematoma was seen in one (3.5%) patient in group 1 and in no patient in group 2 (p = 0.166). Other major complications including extravasations, sepsis, pleural effusion, pelvis perforation, and visceral organ trauma were not seen in any groups. This is the first experience of csPCNL in patients with and without a previous history of renal surgery. We found that there was no difference in results between the two groups that underwent complete supine PCNL. So csPCNL in patients with a history of stone surgery can be safe and effective. csPCNL offers the potential advantages of less patient handling, easier access to the urethra, easier possibility of changing spinal or regional anesthesia to general anesthesia if needed, better airway control and less hazard, especially for patients with compromised cardiopulmonary function, morbid obesity, or those who require a prolonged procedure and easier access to upper calyx. Its popularity is still minimal in the field of urology as a whole, because of fear of colon injury and a lack of training in this position in educational centers.
Literatur
2.
3.
Zurück zum Zitat Sutherland JW, Parks JH, Coe FL (1985) Recurrence after a single renal stone in a community practice. Miner Electrolyte Metab 11:267–269PubMed Sutherland JW, Parks JH, Coe FL (1985) Recurrence after a single renal stone in a community practice. Miner Electrolyte Metab 11:267–269PubMed
4.
Zurück zum Zitat Sahin A, Atsu N, Erdem E et al (2001) Percutaneous nephrolithotomy in patients aged 60 years or older. J Endourol 15:489–491PubMedCrossRef Sahin A, Atsu N, Erdem E et al (2001) Percutaneous nephrolithotomy in patients aged 60 years or older. J Endourol 15:489–491PubMedCrossRef
5.
Zurück zum Zitat Choong S, Whitfield H, Duffy P et al (2000) The management of pediatric urolithiasis. BJUI 86:857–860CrossRef Choong S, Whitfield H, Duffy P et al (2000) The management of pediatric urolithiasis. BJUI 86:857–860CrossRef
6.
Zurück zum Zitat Sahin A, Tekgul S, Erdem E et al (2000) Percutaneous nephrolithotomy in older children. J Pediatr Surg 35:1336–1338PubMedCrossRef Sahin A, Tekgul S, Erdem E et al (2000) Percutaneous nephrolithotomy in older children. J Pediatr Surg 35:1336–1338PubMedCrossRef
7.
Zurück zum Zitat Margel D, Lifshitz DA, Kugel V, Dorfmann D, Lask D, Livne PM (2005) Percutaneous nephrolithotomy in patients who previously underwent open nephrolithotomy. J Endourol 19(10):1161–1164PubMedCrossRef Margel D, Lifshitz DA, Kugel V, Dorfmann D, Lask D, Livne PM (2005) Percutaneous nephrolithotomy in patients who previously underwent open nephrolithotomy. J Endourol 19(10):1161–1164PubMedCrossRef
8.
Zurück zum Zitat Falahatkar S, Afshari Moghaddam A, Salehi M, Nikpour S, Esmaili F, Khaki N (2008) Complete supine percutaneous nephrolithotripsy comparison with the prone standard technique. J Endourol 22(11):2513–2517PubMedCrossRef Falahatkar S, Afshari Moghaddam A, Salehi M, Nikpour S, Esmaili F, Khaki N (2008) Complete supine percutaneous nephrolithotripsy comparison with the prone standard technique. J Endourol 22(11):2513–2517PubMedCrossRef
9.
Zurück zum Zitat Tugcu V, Su FE, Kalfazade N, Sahin S, Ozbay B, Tasci AI (2008) Percutaneous nephrolithotomy(PCNL) in patients with previous open stone surgery. Int Urol Nephrol 40:881–884PubMedCrossRef Tugcu V, Su FE, Kalfazade N, Sahin S, Ozbay B, Tasci AI (2008) Percutaneous nephrolithotomy(PCNL) in patients with previous open stone surgery. Int Urol Nephrol 40:881–884PubMedCrossRef
10.
Zurück zum Zitat Preminger GM, Clayman RV, Hardeman SW et al (1985) Percutaneous nephrostolithotomy vs open surgery for renal calculi: a comparative study. JAMA 254:1054–1058PubMedCrossRef Preminger GM, Clayman RV, Hardeman SW et al (1985) Percutaneous nephrostolithotomy vs open surgery for renal calculi: a comparative study. JAMA 254:1054–1058PubMedCrossRef
11.
Zurück zum Zitat Amiel J, Choong S (2004) Renal stone disease: the urological perspective. Nephron Clin Pract 98:54–58CrossRef Amiel J, Choong S (2004) Renal stone disease: the urological perspective. Nephron Clin Pract 98:54–58CrossRef
12.
Zurück zum Zitat Ruoppolo M, Bellorofonte C, Dell’Acqua S, Zaatar C, Ferri PM, Tagliaferri A, Tombolini P (1990) Complications of percutaneous litholapaxy. Arch Ital Urol Nefrol Androl 62:399–410PubMed Ruoppolo M, Bellorofonte C, Dell’Acqua S, Zaatar C, Ferri PM, Tagliaferri A, Tombolini P (1990) Complications of percutaneous litholapaxy. Arch Ital Urol Nefrol Androl 62:399–410PubMed
13.
Zurück zum Zitat Gremmo E, Ballanger P, Dore B et al (1999) Hemorrhagic complications during percutaneous nephrolithotomy: retrospective studies of 772 cases. Prog Urol 9:460–463PubMed Gremmo E, Ballanger P, Dore B et al (1999) Hemorrhagic complications during percutaneous nephrolithotomy: retrospective studies of 772 cases. Prog Urol 9:460–463PubMed
14.
Zurück zum Zitat Viville C (1987) Percutaneous nephrolithotomy: personal experience in 100 cases. J Urol (Paris) 93:253–258 Viville C (1987) Percutaneous nephrolithotomy: personal experience in 100 cases. J Urol (Paris) 93:253–258
15.
Zurück zum Zitat Viville C (1988) Treatment of staghorn calculi by percutaneous nephrolithotomy: apropos of 18 cases. J Urol (Paris) 94:133–136 Viville C (1988) Treatment of staghorn calculi by percutaneous nephrolithotomy: apropos of 18 cases. J Urol (Paris) 94:133–136
16.
Zurück zum Zitat Falahatkar S, Panahandeh Z, Ashoori E, Akbarpour M, Khaki N (2009) What is the difference between percutaneous nephrolithotomy in patients with and without previous open renal surgery? J Endourol 23(7):1107–1110PubMedCrossRef Falahatkar S, Panahandeh Z, Ashoori E, Akbarpour M, Khaki N (2009) What is the difference between percutaneous nephrolithotomy in patients with and without previous open renal surgery? J Endourol 23(7):1107–1110PubMedCrossRef
17.
Zurück zum Zitat Falahatkar S, Enshaei A, Afsharimoghaddam A, Emadi SA, Allahkhah A (2010) Complete supine percutaneous nephrolithotomy with lung inflation avoids the need for a supracostal puncture. J Endourol 24(2):213–218PubMedCrossRef Falahatkar S, Enshaei A, Afsharimoghaddam A, Emadi SA, Allahkhah A (2010) Complete supine percutaneous nephrolithotomy with lung inflation avoids the need for a supracostal puncture. J Endourol 24(2):213–218PubMedCrossRef
18.
Zurück zum Zitat Sofikerim M, Demirci D, Gulmez I et al (2007) Does previous open nephrolithotomy affect the outcome of percutaneous nephrolithotomy? J Endourol 21:401–403PubMedCrossRef Sofikerim M, Demirci D, Gulmez I et al (2007) Does previous open nephrolithotomy affect the outcome of percutaneous nephrolithotomy? J Endourol 21:401–403PubMedCrossRef
19.
Zurück zum Zitat Basiri A, Karrami H, Moghaddam SM et al (2003) Percutaneous nephrolithotomy in patients with or without a history of open nephrolithotomy. J Endourol 17:213–216PubMedCrossRef Basiri A, Karrami H, Moghaddam SM et al (2003) Percutaneous nephrolithotomy in patients with or without a history of open nephrolithotomy. J Endourol 17:213–216PubMedCrossRef
21.
Zurück zum Zitat Lojanapiwat B (2006) Previous open nephrolithotomy: does it affect percutaneous nephrolithotomy techniques and outcome? J Endourol 20:17–20PubMedCrossRef Lojanapiwat B (2006) Previous open nephrolithotomy: does it affect percutaneous nephrolithotomy techniques and outcome? J Endourol 20:17–20PubMedCrossRef
Metadaten
Titel
Complete supine percutaneous nephrolithotomy (csPCNL) in patients with and without a history of stone surgery: safety and effectiveness of csPCNL
verfasst von
Siavash Falahatkar
Mani Mohiti Asli
Seyedeh Atefeh Emadi
Ahmad Enshaei
Hedayat Pourhadi
Aliakbar Allahkhah
Publikationsdatum
01.08.2011
Verlag
Springer-Verlag
Erschienen in
Urolithiasis / Ausgabe 4/2011
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-010-0341-y

Weitere Artikel der Ausgabe 4/2011

Urolithiasis 4/2011 Zur Ausgabe

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Fehlerkultur in der Medizin – Offenheit zählt!

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.